Singapore, March 20, 2008: 3Sbio, a China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, has appointed Dr David Chen to the newly created role of Executive Vice President and Chief Operating Officer (COO), effective immediately. Dr Chen most recently held the position of Vice President of Business Development at 3SBio.

 

Since joining 3SBio in June 2007, Dr Chen has been responsible for developing long-range growth strategies and pursuing strategic business opportunities and external alliances with biotechnology and pharmaceutical companies in major markets worldwide. In addition to his existing responsibilities, Dr Chen will assume oversight of commercial operations including commercial strategy, medical and regulatory, government affairs, and export. He will be based in Beijing.